ArticleDiscover oncology2025
Two case reports on central nervous system metastasis from nasopharyngeal carcinoma and a literature review.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nasopharyngeal carcinoma (NPC) is a common malignant tumor in Southern China. The clinical manifestations, including extensive local invasion and distant metastasis, exhibit certain patterns. As we know, the most common sites of distant failure are bone, liver and lung. Although intracranial invasion by direct extension from the nasopharynx through the skull base in patients with locally advanced disease is not uncommon, metastasis to the central nervous system (CNS) is very scarce. We analyzed and summarized the literature about central nervous system metastasis of NPC by reviewing the English database. Most patients have other common site metastasis at the same time or successively. Spread through the cerebral spinal fluid (CSF) and hematogenous dissemination were common routes of CNS metastasis, and the sites of metastasis were irregular. Aggressive surgical resection with or without postoperative radiotherapy conferred reasonable survival and symptom control. Here, we report two patients with NPC who developed CNS metastases. These two cases highlight the effectiveness of personalized multimodal therapy, including surgery, precision radiotherapy, and chemotherapy, in NPC with CNS metastasis, offering a potential framework for similar cases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.